Search

everythinglearnresearchcommunity

for

Search:↓

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

A woman with multiple autoimmune diseases showed improvement in hair loss but not in skin discoloration after treatment.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Cytokines are important for immune responses and treating diseases, but they can cause side effects like fever and skin issues.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

A Pug with skin issues was successfully treated for mite and bacterial infections.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Targeted cancer therapies often cause serious skin problems that need careful management.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Nanocapsules can improve clobetasol delivery to hair follicles, reducing side effects.

Dermal exosomes with miR-218-5p boost hair growth by controlling β-catenin signaling.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.